Financial Performance

Career colleges are booming as students flee AI, yet face intense pressure to adopt it. A new firm claims its bespoke approach can deliver massive ROI without the chaos.

Beyond simple comfort, your next HVAC is a major investment. We break down the tech, costs, and policies shaping the heat pump, furnace, and hybrid debate.

A new report reveals a startling trend: as AI adoption soars, financial firms are increasingly banning communication channels, a defensive move creating new risks.

A new three-year study shows listings promoted via agent-to-agent email blasts went pending 30% faster. The real story is how this advantage widens as markets cool.

As AI agents act with growing autonomy inside business tools, a new solution from MSPAlliance offers unprecedented visibility, shifting risk from a guess to a science.

With a key webinar ahead, Arrowhead Pharma is showcasing a trio of gene-silencing drugs. Can its TRiM™ platform upend a multi-billion dollar cardiometabolic market?

A new Slovak fintech offers zero-fee ETF investing to fight inflation. But what's the catch? We analyze the business model shaking up Central European finance.

A new patent gives CervoMed a long runway for its dementia drug, but can this IP victory secure the massive funding needed to cross the finish line?

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Lotus Tech's new sustainability report isn't just about green goals; it's a strategic play for investor trust with zero recalls and ambitious carbon targets.

Hisense's VAR role at the World Cup is more than a tech deal. It's a high-stakes play to enhance game integrity, dominate a market, and redefine fan experience.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.

A2MAC1's Tset acquisition is set to redefine automotive cost management, blending deep data with AI simulation to create a dynamic decision-making engine.

Hisense enters Hong Kong with a flagship store, leveraging World Cup fever to showcase its premium RGB MiniLED TVs and signaling a strategic push into the GBA.

As CFO Dave Denton departs for the consumer goods sector, Pfizer taps a 20-year veteran for the interim role, signaling continuity amid a crucial post-acquisition phase.

Opendorse is pivoting from an NIL marketplace to a commerce engine, launching Athlete Commerce Media to directly link college athlete influence to sales at major retailers.

Beyond a simple merger, Conrex Group's acquisition of Formweld Fitting signals a strategic shift toward creating a resilient, one-stop industrial giant.